Cargando…
Ocoxin Oral Solution Exerts an Antitumoral Effect in Pancreatic Cancer and Reduces the Stromal-Mediated Chemoresistance
OBJECTIVES: Pancreatic carcinoma is one of the most aggressive cancers overcoming chemoresistance. Thus, novel compounds to complement the current antitumor agents are in need. Ocoxin oral solution (OOS) has proven antioxidant, anti-inflammatory, and antistromagenic properties. The aim of this study...
Autores principales: | Hernandez-Unzueta, Iera, Benedicto, Aitor, Romayor, Irene, Herrero, Alba, Sanz, Eduardo, Arteta, Beatriz, Olaso, Elvira, Márquez, Joana |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Lippincott Williams & Wilkins
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6493672/ https://www.ncbi.nlm.nih.gov/pubmed/30946238 http://dx.doi.org/10.1097/MPA.0000000000001277 |
Ejemplares similares
-
Ocoxin oral solution(®) as a complement to irinotecan chemotherapy in the metastatic progression of colorectal cancer to the liver
por: Hernandez-Unzueta, Iera, et al.
Publicado: (2017) -
Ocoxin(®) oral solution slows down tumor growth in an experimental model of colorectal cancer metastasis to the liver in Balb/c mice
por: MÁRQUEZ, JOANA, et al.
Publicado: (2016) -
Ocoxin Increases the Antitumor Effect of BRAF Inhibition and Reduces Cancer Associated Fibroblast-Mediated Chemoresistance and Protumoral Activity in Metastatic Melanoma
por: Benedicto, Aitor, et al.
Publicado: (2021) -
Improving the Antitumor Effect of Chemotherapy with Ocoxin as a Novel Adjuvant Agent to Treat Prostate Cancer
por: Hernandez-Unzueta, Iera, et al.
Publicado: (2023) -
Inhibition of COX-2 Impairs Colon Cancer Liver Metastasis through Reduced Stromal Cell Reaction
por: Herrero, Alba, et al.
Publicado: (2021)